Ani Pharmaceuticals (ANIP) Cash & Equivalents (2010 - 2026)
Ani Pharmaceuticals' Cash & Equivalents was $360.21 million in Q2 2026, up 65.4% from $217.83 million a year earlier and up 15.8% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Ani Pharmaceuticals came in at $285.59 million, up 97.1% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 105.1% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $144.89 million in FY2024 (-34.5%), $221.12 million in FY2023 (+358.5%), $48.23 million in FY2022 (-51.9%) and $100.3 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Cash & Equivalents in data going back to Q2 2010.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 31.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2023 (growth of 358.5%); the worst was Q4 2022 (a decline of 51.9%).
- Per Business Quant data, ANIP's Cash & Equivalents in the three quarters before Q2 2026 was $311.18 million (Q1 2026), $285.59 million (Q4 2025) and $262.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Ani Pharmaceuticals | 1.72 Bn | 502.13 Mn | 165.89 Mn | 360.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 360.21 Mn |
| Mar 31, 2026 | 311.18 Mn |
| Dec 31, 2025 | 285.59 Mn |
| Sep 30, 2025 | 262.61 Mn |
| Jun 30, 2025 | 217.83 Mn |
| Mar 31, 2025 | 149.80 Mn |
| Dec 31, 2024 | 144.89 Mn |
| Sep 30, 2024 | 144.98 Mn |
| Jun 30, 2024 | 240.11 Mn |
| Mar 31, 2024 | 228.60 Mn |
| Dec 31, 2023 | 221.12 Mn |
| Sep 30, 2023 | 193.08 Mn |
| Jun 30, 2023 | 161.71 Mn |
| Mar 31, 2023 | 67.76 Mn |
| Dec 31, 2022 | 48.23 Mn |
| Sep 30, 2022 | 56.28 Mn |
| Jun 30, 2022 | 63.39 Mn |
| Mar 31, 2022 | 76.91 Mn |
| Dec 31, 2021 | 100.30 Mn |
| Sep 30, 2021 | 15.25 Mn |
API Access
Ani Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();